PeptideStack

AHK-Cu

Explore AHK-Cu, a potent copper peptide researched for hair growth and follicle stimulation. Learn about AHK-Cu benefits, mechanisms, and side effects.

Last updated:

Administration
topical
Origin
Synthetic (Copper Peptide)

Overview

AHK-Cu is a synthetic copper peptide primarily researched for its potential to stimulate hair growth and improve skin health. This tripeptide-copper complex works by promoting the proliferation of dermal papilla cells and reducing apoptosis in hair follicles. Researchers are highly interested in the AHK-Cu peptide as a topical agent for combating androgenetic alopecia and supporting overall follicular vitality. By modulating key cellular pathways, AHK-Cu offers a promising avenue for regenerative medicine and advanced dermatological treatments.

Potential Benefits

  • Hair Follicle Stimulation: Research indicates AHK-Cu promotes the proliferation of human dermal papilla cells, which are crucial for initiating and maintaining active hair growth (Pyo et al., 2007).
  • Apoptosis Reduction: The peptide has been shown to decrease programmed cell death in hair follicles, potentially extending the anagen phase of the hair cycle for thicker hair.
  • Increased Blood Flow: Copper peptides like AHK-Cu are believed to stimulate angiogenesis, improving microcirculation and ensuring optimal nutrient and oxygen delivery to the scalp.
  • Collagen Production: Studies suggest copper complexes enhance the synthesis of collagen and elastin, improving the structural integrity of the skin and providing a healthier foundation for hair.
  • Anti-Inflammatory Properties: AHK-Cu may help reduce local scalp inflammation by modulating immune responses, creating a more favorable and less oxidative environment for healthy hair development.
  • Oxidative Stress Protection: By protecting cells from oxidative stress, the AHK-Cu peptide helps maintain cellular health and prevents premature aging of the hair follicles.

Side Effects

Common side effects:

  • Mild scalp irritation at the application site
  • Temporary redness or erythema
  • Itching or pruritus
  • Dry skin or localized flaking

Rare or serious side effects:

  • Allergic contact dermatitis
  • Systemic copper toxicity with excessive use
  • Unintended changes in hair texture or color

AHK-Cu is not FDA-approved and is intended for research purposes only. Consult a qualified healthcare provider before use.

Mechanism of Action

Cellular Proliferation is the primary mechanism by which the AHK-Cu peptide exerts its regenerative effects on hair follicles. It specifically targets dermal papilla cells, upregulating the production of vascular endothelial growth factor (VEGF) and promoting rapid cellular division to support the anagen growth phase. This targeted stimulation ensures that follicles remain active and capable of producing robust hair shafts. Apoptosis Inhibition further enhances these AHK-Cu benefits by downregulating Bax, a pro-apoptotic protein, and upregulating Bcl-2, an anti-apoptotic protein. This molecular shift delays the catagen phase, effectively preventing premature hair follicle regression and maintaining active hair growth over extended periods (Pyo et al., 2007).

Origin & History

Discovery and Development of AHK-Cu stems from broader research into copper-binding peptides, specifically building upon the foundational success of the well-known GHK-Cu peptide. Scientists isolated the alanyl-histidyl-lysine (AHK) sequence to optimize its binding affinity for copper and to enhance its specific efficacy in dermal and follicular applications. This targeted development aimed to create a more potent compound for hair restoration. Regulatory Status currently designates the AHK-Cu peptide strictly as a research-only chemical across most global jurisdictions. It has not been approved by the FDA for human therapeutic use or as a medical treatment. However, it remains a subject of intense investigation in cosmetic science and dermatology for potential future applications in topical hair loss treatments.

Frequently Asked Questions

Research & Resources

PubMed Studies

View all studies on PubMed →

Data last updated: April 3, 2026

Related Peptides